MD Conference Express ACC 2012 - (Page 5)

Robert P Giugliano, MD, SM . Brigham and Women’s Hospital, USA Features PRESENTS OFFICIAL HIGHLIGHTS OF THE American College of Cardiology 61st Annual Scientific Cardiology The European Society ofSession/i2 Summit 2008 Annual24 - 27, 2012 Meeting March LEAD CARDIOLOGY ADVISORS 8 Treatment of AMI in the Post-Herrick Era Peer-Reviewed CARDIOLOGY 10 The State of Hypertension Guidelines: 2012 Clinical Trial Highlights 12 ACRIN PA 4005: Coronary CTA in the ED Identifies Low-Risk Patients and Shortens Length of Stay 13 One-Year STAMPEDE Trial Results 14 TAVR Associated with Increased Late Mortality from Paravalvular Regurgitation 15 The CABG Surgery Off- or On- PumpRevascularization Study (CORONARY) 15 The Moderate PE Treated with Thrombolysis Study (MOPETT) 16 Pacemaker Therapy In Patients With Neurally Mediated Syncope and Documented Asystole 17 Outcomes from the BRIDGE-ACS Trial 20 ROMICAT II: More Data Evaluating CT-First for Acute Chest Pain ED Triage 21 Elective PCI at Community Hospitals With Versus Without On-Site Surgery 23 Results from the TRA 2P-TIMI 50 Trial 23 The HOST-ASSURE Randomized Trial 24 New Monoclonal Antibody to PCSK9 Markedly Lowers LDL-C in Patients on Atorvastatin 25 Oral Rivaroxaban Alone for Symptomatic PE 26 Neutral Outcomes But Important Insights From FOCUS-CCTRN Therapeutic Updates 27 Imaging 30 STEMI 32 Acute Coronary Syndrome 34 Antiplatelet Therapy Other News 37 The New Hypertrophic Cardiomyopathy Practice Guidelines Scientific Sessions PRESENTS OFFICIAL HIGHLIGHTS OF Chicago, Illinois, USA Munich, Germany August 30—September 4, 2008 Breaking News ACC-i2 with innovation in intervention March 24 – 27, 2012 • CHICAGO Therapy Updates Exhibits: March 24 – 26 Robert P Giugliano, MD, SM . Brigham and Women’s Hospital, USA Marc P. Bonaca, MD, MPH Brigham and Women's Hospital, USA Jacob A. Udell, MD, MPH Brigham and Women's Hospital, USA Treatment of AMI in the Post-Herrick Era The 2012 Simon Dack Lecture delved into the early gains that were made in the treatment of acute myocardial infarction, making note that the field has changed dramatically since 1912, when James B. Herrick, MD, postulated that thrombosis in the coronary artery leads to the symptoms and abnormalities that are associated with heart attacks [Herrick JB. JAMA 1912]. Eugene Braunwald, MD, MACC, covered the major advances over the subsequent 100 years and provided a vision for cardiovascular medicine in the coming century. See Page 8. Distribution of this independent report is supported by INTERNATIONAL MEDICAL ADVISORY BOARD INTERNATIONAL MEDICAL ADVISORY BOARD Giraldez, MD Olakunle O. Akinboboye, MD Roberto R. ALSO IN THIS ISSUE • Hypertension Guidelines: 2012 • Clinical Trial Highlights – The Science Behind Cardiology • State of the Art in STEMI Care Philip E. Aylward, BM BCh, PhD Milan Luknar, MD das New York Hospital Queens Heart Institute - Hospital Clinicas Flinders Medical Centre, Australia National Institute of Cardiovascular Martin J. Abrahamson, MD Disease, Messineo, MD Frank C.Slovak Republic Edmund Chada Baracat, MD Beth Israel Deaconess Raymond Massay, MD Medical Center New York Hospital Queens Scientific Director, President, Brazilian MedicalCenter Joslin Diabetes Association Tore Kvien, MD Caribbean Cardiac Society Jeroen J. Bax, MD, PhD Heinz Burgmann, MD Diakonhjemmet Hospital, Elizabeth Mayer-Davis, PhD Past-President, EULAR Leiden University Medical Center, University of Vienna President, Health Care & Education, The Netherlands Nussbaum, Harold J. Burstein, MD, PhD Michel E.Diabetes Association American MD, FACP Ramon Corbalán, MD Dana-Farber Cancer Insitute Toyoaki Murohara, MD, PhD Pontificia Universidad Católica, Chile New York Hospital Queens Daniel J. DeAngelo, MD, PhD Nagoya University, Japan Anthony J. Dalby MB, ChB, FCP Patrick Ying, MD Dana-Farber Cancer Institute Ernesto Paolasso, MD NYU Medical Center Milpark Hospital, South Africa Gary W. Falk, MD, MS Instituto de Investigaciones Joanna J. Wykrzykowska, MD Anthony N.Clinic DeMaria, MD Clínicas de Rosario, Argentina Cleveland Beth Israel Deaconess Editor-in-Chief, JACC Anne L. Peters, MD, FACP CDE , Apostolos Georgopoulos, MD Medical Center Jean-Pierre Després, PhD Univ. of Southern California, USA University of Vienna Université Laval, Canada Fausto Pinto, MD Robert P Giugliano, MD, SM . Vivian A. Fonseca, MD, FRCP CPC Chair, European Society of Brigham & Women’s Hospital Tulane University, USA Cardiology Congress 2009-2010 Timothy J. Gardner, MD Christiana Care Center for Heart & Vascular Health, USA Hiroaki Shimokawa, MD, PhD Editor-in Chief, Japanese Circulation Journal PUBLISHER 98 Oxford Street Suite #1 Arlington, MA 02474 USA Tel.: +1-617-515-9797 E-mail: reports [at] goodwingroupintl.com Eva Gonçalvesova, MD, PhD Jennifer Goodwin Andrew F. Stewart, MD Publisher President, Vice President, BethPast-Chair, ADA Scientific Sessions Johnson Slovak Society of Cardiology Chuwa Tei, MD Publishing Robert R. Henry, MD President, Japanese College of Associate Director, Heather Q. Sinclair President, Medicine & Science, Cardiology Publishing American Diabetes Association Lauren Valone Production Assistant Neil Canavan Medical Writers STAFF MedCom Depot President Jennifer Schünemann Design IntuitDesign Vice President, Beth Johnson Publishing Production Manager Lauren Valone SALES Lori Alexander Medical Writers Jennifer Goodwin Tel.: +1-617-515-9797 Rita Buckley Maria Vinall EDITORIAL STAFF BUSINESS DEVELOPMENT Jennifer Schünemann Tel.: +1-617-515-9797 www.mdconferencexpress.com reports [at] goodwingroupintl.com +1-617-515-9797 The publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied herein, nor for any opinion expressed. The publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from this report. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the publisher. All articles are peer-reviewed and protected from any commercial influence. 38 New Anti-Diabetes Agents Offer Promise in the Fight Against CVD © MD Conference Express®. All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of The Goodwin Group International, LLC. MD Conference Express is a registered trademark of The Goodwin Group International, LLC. ISSN 1559-8977 ISSN 2155-756X  http://www.mdconferencexpress.com http://www.goodwingroupintl.com http://www.facebook.com/mdconferencexpress http://visitor.r20.constantcontact.com/manage/optin/ea?v=001BdwJNcIEVTgv4LtUJBUDeg%3D%3D http://www.mdconferencexpress.com http://www.goodwingroupintl.com

Table of Contents for the Digital Edition of MD Conference Express ACC 2012

MD Conference Express ACC 2012
Table of Contents
Treatment of AMI in the Post-Herrick Era
The State of Hypertension Guidelines: 2012
ACRIN PA 4005: Coronary CTA in the ED Identifies Low-Risk Patients and Shortens Length of Stay
One-Year STAMPEDE Trial Results
TAVR Associated with Increased Late Mortality from Paravalvular Regurgitation
The CABG Surgery Off- or On- Pump- Revascularization Study (CORONARY)
The Moderate PE Treated with Thrombolysis Study (MOPETT)
Pacemaker Therapy In Patients With Neurally Mediated Syncope and Documented Asystole
Outcomes from the BRIDGE-ACS Trial
ROMICAT II: More Data Evaluating CT-First for Acute Chest Pain ED Triage
Elective PCI at Community Hospitals With Versus Without On-Site Surgery
Results from the TRA 2P-TIMI 50 Trial
The HOST-ASSURE Randomized Trial
New Monoclonal Antibody to PCSK9 Markedly Lowers LDL-C in Patients on Atorvastatin
Oral Rivaroxaban Alone for Symptomatic PE
Neutral Outcomes But Important Insights From FOCUS-CCTRN
Imaging
STEMI
Acute Coronary Syndrome
Antiplatelet Therapy
New Anti-Diabetes Agents Offer Promise in the Fight Against CVD
The New Hypertrophic Cardiomyopathy Practice Guidelines

MD Conference Express ACC 2012

https://www.nxtbook.com/nxtbooks/md_conference_express/acc2013
https://www.nxtbook.com/nxtbooks/md_conference_express/acc2012
https://www.nxtbookmedia.com